Presentation Information
[O7-02]A Phase I Study to Evaluate a Live Attenuated Tetravalent Dengue Vaccine (KD 382) in Flavivirus Antibody-Naïve Healthy Adults
*Motoharu Abe1, Yasuhiko Shinmura1, Yukiko Mitsuhiro1, Yuta Uchida1, Yusuke Ohyama1, Tetsuro Tanabe1, Kengo Sonoda1 (1. KM Biologics Co., Ltd.)